Tag:
Vioxx
Latest Headlines
Latest Headlines
Medical data mining can predict adverse drug events
Researchers for the RAND Corp. have determined that it's possible to mine medical literature to find out whether studies involving particular medications can predict patient harm from those drugs.
MA anesthesiologist accused of fabricating 21 studies
While we at FierceHealthcare have covered all kinds of allegations regarding skulduggery in the research business, particularly questionable behavior that advances pharmaceutical company interests.
Justice Department recovers $1.12 billion from fraud
Every year the Justice Department tries to recover as much as it can from healthcare organizations that have allegedly defrauded them: this year the total it recovered was $1.12 billion dollars. This
FL sues Merck over Vioxx marketing
Florida's Attorney General has filed suit against Merck & Co., again, this time for allegedly deceptive marketing and promotion of joint pain drug Vioxx. The suit claims that Merck failed
Merck agrees to $58M settlement on Vioxx ads
Merck has agreed to a $58 million settlement with 29 states and the District of Columbia to settle allegations that it downplayed heart risks created by Vioxx in direct-to-consumer advertising. Under
Studies show problems with four big-name drugs
It looks like yet another set of popular drugs are facing allegations that they pose safety risks. Drugs named this week in unfavorable studies include Fosamax, which may create heart problems for
ALSO NOTED: Demand for health IT pros to soar; Pharmas lobbying hard in DC; and much more...
> Industry researchers are predicting that it will take a huge increase in the volume of professionals available (more than 40,000) to meet the near-term demand for skilled health IT pros.
Reports suggest that Merck downplayed Vioxx risks
Another day, another report suggesting that a pharmaceutical company tried to bury data impugning the safety of one of its products. This time, a study has been published in The Journal of the
WellPoint, FDA collaborate on tracking drug safety
Now here's an interesting partnership--one that likely will generate some valuable results. WellPoint and the FDA have agreed to work together to create a real-time drug-surveillance system to look
ALSO NOTED: AIDS vaccine back at square one; What's behind the FDA's low drug approval rating?; and much more...
> After trying and failing repeatedly to develop an AIDS vaccine, federal officials say they're going back to the drawing board to come up with some new ideas.
